Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies
- PMID: 21292721
- PMCID: PMC3033438
- DOI: 10.1136/bmj.d35
Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies
Abstract
Objective: To review the association between current enterovirus infection diagnosed with molecular testing and development of autoimmunity or type 1 diabetes.
Design: Systematic review and meta-analysis of observational studies, analysed with random effects models.
Data sources: PubMed (until May 2010) and Embase (until May 2010), no language restrictions, studies in humans only; reference lists of identified articles; and contact with authors. Study eligibility criteria Cohort or case-control studies measuring enterovirus RNA or viral protein in blood, stool, or tissue of patients with pre-diabetes and diabetes, with adequate data to calculate an odds ratio and 95% confidence intervals.
Results: The 24 papers and two abstracts (all case-control studies) that met the eligibility criteria included 4448 participants. Study design varied greatly, with a high level of statistical heterogeneity. The two separate outcomes were diabetes related autoimmunity or type 1 diabetes. Meta-analysis showed a significant association between enterovirus infection and type 1 diabetes related autoimmunity (odds ratio 3.7, 95% confidence interval 2.1 to 6.8; heterogeneity χ(2)/df = 1.3) and clinical type 1 diabetes (9.8, 5.5 to 17.4; χ(2)/df = 3.2).
Conclusions: There is a clinically significant association between enterovirus infection, detected with molecular methods, and autoimmunity/type 1 diabetes. Larger prospective studies would be needed to establish a clear temporal relation between enterovirus infection and the development of autoimmunity and type 1 diabetes.
Conflict of interest statement
Competing interests: All authors have completed the Unified Competing Interest form at
Figures
Comment in
-
Enteroviruses and type 1 diabetes.BMJ. 2011 Feb 3;342:c7072. doi: 10.1136/bmj.c7072. BMJ. 2011. PMID: 21292717 No abstract available.
Similar articles
-
Maternal virus infections in pregnancy and type 1 diabetes in their offspring: Systematic review and meta-analysis of observational studies.Rev Med Virol. 2018 May;28(3):e1974. doi: 10.1002/rmv.1974. Epub 2018 Mar 22. Rev Med Virol. 2018. PMID: 29569297
-
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2. Cochrane Database Syst Rev. 2022. PMID: 35199850 Free PMC article.
-
Antibody tests for identification of current and past infection with SARS-CoV-2.Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2. Cochrane Database Syst Rev. 2022. PMID: 36394900 Free PMC article.
-
Intracavity lavage and wound irrigation for prevention of surgical site infection.Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD012234. doi: 10.1002/14651858.CD012234.pub2. Cochrane Database Syst Rev. 2017. PMID: 29083473 Free PMC article.
-
Different insulin types and regimens for pregnant women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Feb 3;2(2):CD011880. doi: 10.1002/14651858.CD011880.pub2. Cochrane Database Syst Rev. 2017. PMID: 28156005 Free PMC article.
Cited by
-
Enterovirus infection of human islets of Langerhans affects β-cell function resulting in disintegrated islets, decreased glucose stimulated insulin secretion and loss of Golgi structure.BMJ Open Diabetes Res Care. 2016 Aug 10;4(1):e000179. doi: 10.1136/bmjdrc-2015-000179. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27547409 Free PMC article.
-
Cytokine and chemokine production by human pancreatic islets upon enterovirus infection.Diabetes. 2012 Aug;61(8):2030-6. doi: 10.2337/db11-1547. Epub 2012 May 17. Diabetes. 2012. PMID: 22596052 Free PMC article.
-
Immunology in the clinic review series; focus on type 1 diabetes and viruses: role of antibodies enhancing the infection with Coxsackievirus-B in the pathogenesis of type 1 diabetes.Clin Exp Immunol. 2012 Apr;168(1):47-51. doi: 10.1111/j.1365-2249.2011.04559.x. Clin Exp Immunol. 2012. PMID: 22385236 Free PMC article. Review.
-
The COVID-19 Pandemic Increased the Incidence of New-Onset Type One Diabetes in Children.Children (Basel). 2024 Jan 23;11(2):142. doi: 10.3390/children11020142. Children (Basel). 2024. PMID: 38397254 Free PMC article.
-
Anti-coxsackievirus B4 (CV-B4) enhancing activity of serum associated with increased viral load and pathology in mice reinfected with CV-B4.Virulence. 2017 Aug 18;8(6):908-923. doi: 10.1080/21505594.2016.1252018. Epub 2016 Oct 28. Virulence. 2017. PMID: 27792461 Free PMC article.
References
-
- Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 2010;6:279-89. - PubMed
-
- Diamond PG. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66. - PubMed
-
- EURODIAB. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000;355:873-6. - PubMed
-
- Patterson C, Dahlquist G, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-33. - PubMed
-
- Chong J, Craig M, Cameron F, Clarke C, Rodda C, Donath S, et al. Marked increase in type 1 diabetes mellitus incidence in children aged 0-14 yrs in Victoria, Australia, from 1999 to 2002. Pediatr Diabetes 2007;8:67-73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous